Samuel-Freshfields.com Life Sciences Fund wins Awards in the Global Health/Biotechnology classification.
(1888PressRelease) May 20, 2022 - Samuel Freshfields, a next generation investment company that aims to give its clients access to a broad range of financial instruments, promoting the highest standards of integrity, responsibility, and competence to produce a highly personalized counseling process, is pleased to announce that Samuel Freshfields Life Sciences Fund received Industry Fund Awards as the Best Health/Biotechnology Fund.
"The industry’s recognition of Samuel Freshfields Life Sciences Fund reinforces the value of our fundamental, bottom-up investment approach," said Xiong Wenbin, Chief Information Officer of Equities and Asset Allocation with Samuel Freshfields. "Our approach to risk-management and diversification helped the Fund navigate the market swings of the past years while continuing to produce great results for clients," added Mr. Wenbin.
The Industry Awards honor fund management firms and individual mutual funds that excel in delivering consistently strong, risk-adjusted performance relative to their peers. Annual Industry Awards reflect consistency of return over time. They take into account both short- and long- term risk-adjusted performance relative to a fund's classification and look back over a variety of holding periods.
"Samuel Freshfields has been deservedly recognized for the performance of its Samuel Freshfields Life Sciences Fund which stood apart from its peers by impressively winning the Industry Fund Award for all three eligible time periods in the global health/biotechnology classification," said Ding Xiaoming, Senior Research Analyst. "The awards are certainly a positive reflection of the investment process that Samuel Freshfields has in place in the global health/biotechnology sectors", added Mr. Xiaoming.
Samuel Freshfields Life Sciences Fund seeks to identify high quality or improving businesses in the life sciences sector that trade at a discount to our estimate of intrinsic value. The fund uses the power of Samuel Freshfields' deep fundamental research to seek opportunities across the health care spectrum and around the world, with a strong focus on businesses that address unmet medical needs or make the health care system more efficient.
About Samuel Freshfields
Samuel-Freshfields.com is a next generation investment company that aims to give its clients access to a broad range of financial instruments and markets as well as professional advice to maximize returns. Samuel Freshfields’ investment advisory and brokerage services are multidisciplinary, allowing the company to devise custom strategies and deliver exceptional results for our clients. The company’s major goal has been to work hand-in-hand with clients to meet their investment needs. While many financial firms push one-size-fits-all products, Samuel Freshfields strives to coordinate the fundamental disciplines of the company’s dividend-growth philosophy with the unique needs of our clients regarding the growth, use and preservation of their wealth.
Samuel-Freshfields.com Life Sciences Fund wins Awards in the Global Health/Biotechnology classification. 
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam